Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: diversifying licensees
I have thought the same thing for quite awhile now. I believe the amount of shares held by long time longs and those that bought in 2006 and are hanging on amounts to a very substantial percentage of available shares. People do not know me, but I have been here since '99 and hold what I consider a large position and I am not buying anymore. Same situation I'll bet for hundreds out there. As you say, with no new promotion we are seeing no new blood buying in and the rest of us are sitting tight.
Share
New Message
Please login to post a reply